6339-04-4 Usage
Uses
Used in Laboratory and Research Settings:
SALOR-INT L497096-1EA is used as a reagent, catalyst, or precursor for facilitating various chemical reactions and processes. Its unique properties and reactivity make it a valuable component in these settings.
Used in Organic Synthesis:
In the field of organic synthesis, SALOR-INT L497096-1EA is used as a reagent or catalyst to aid in the formation of desired organic compounds, contributing to the development of new chemical entities.
Used in Pharmaceutical Manufacturing:
SALOR-INT L497096-1EA may be employed in the production of pharmaceuticals, where it could act as a key intermediate or catalyst in the synthesis of drug molecules, enhancing the efficiency and selectivity of the manufacturing process.
Used in Material Science:
In material science, SALOR-INT L497096-1EA could be utilized in the development of new materials or the improvement of existing ones, potentially influencing properties such as reactivity, stability, or functionality.
It is crucial to handle SALOR-INT L497096-1EA with care and adhere to proper safety protocols to minimize any potential hazards associated with its use.
Check Digit Verification of cas no
The CAS Registry Mumber 6339-04-4 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 6,3,3 and 9 respectively; the second part has 2 digits, 0 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 6339-04:
(6*6)+(5*3)+(4*3)+(3*9)+(2*0)+(1*4)=94
94 % 10 = 4
So 6339-04-4 is a valid CAS Registry Number.
InChI:InChI=1/C10H11NO4/c1-7(12)11-8-3-2-4-9(5-8)15-6-10(13)14/h2-5H,6H2,1H3,(H,11,12)(H,13,14)
6339-04-4Relevant academic research and scientific papers
PRMT5 INHIBITORS AND USES THEREOF
-
Paragraph 0316-0317, (2019/04/05)
Described herein are compounds of Formula (I), pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof. Compounds of the present invention are useful for inhibiting PRMT5 activity. Methods of using the compounds for treating PRMT5-mediated disorders are also described.
PRMT5 INHIBITORS CONTAINING A DIHYDRO- OR TETRAHYDROISOQUINOLINE AND USES THEREOF
-
Paragraph 00296, (2014/07/08)
Described herein are compounds of Formula (A), pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof. Compounds of the present invention are useful for inhibiting PRMT5 activity. Methods of using the compounds for treating PRMT5- mediated disorders are also described.
